Midori Shima

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Helicobacter Pylori Infection

Diffusion Weighted

Juvenile Idiopathic Arthritis

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Research and practice in thrombosis and haemostasis

This page only lists publications with an associated author ORCID identifier.

Publications

Yuya Mawarikado, Asuka Sakata, Yusuke Inagaki, Suguru Harada, Kohei Tatsumi, Naoki Matsumoto, Kenichi Ogiwara, Koji Yada, Yasushi Yoshimura, Akira Kido, Yasuhito Tanaka, Midori Shima, Keiji Nogami
Force-sensing treadmill gait analysis system can detect gait abnormalities in haemophilia patients without arthropathy. Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Yuya Mawarikado, Asuka Sakata, Yusuke Inagaki, Suguru Harada, Kohei Tatsumi, Naoki Matsumoto, Kenichi Ogiwara, Koji Yada, Yasushi Yoshimura, Akira Kido, Yasuhito Tanaka, Midori Shima, Keiji Nogami
Force-sensing treadmill gait analysis system can detect gait abnormalities in haemophilia patients without arthropathy. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Masahiro Takeyama, Naoki Ozu, Shu Kasama, Masato Kasahara, Masanori Matsumoto, Midori Shima, Keiji Nogami
Study protocol for assessment of the coagulation potential of concomitantly used factor VIII concentrates in patients with haemophilia A with emicizumab prophylaxis (CAGUYAMA Study): a multicentre open-label non-randomised clinical trial. BMJ open 13 (7) (2023)
Charles R M Hay, Michael P Makris, Midori Shima, Azusa Nagao, Víctor Jiménez-Yuste, Mark W Skinner, Craig M Kessler, Sylvia von Mackensen
Association of patient, treatment and disease characteristics with patient-reported outcomes: Results of the ECHO Registry. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Yuya Mawarikado, Asuka Sakata, Yusuke Inagaki, Daisuke Shirai, Kohei Tatsumi, Keiji Nogami, Yasuhito Tanaka, Akira Kido, Midori Shima
Single-facility study of the effectiveness of rehabilitation therapy using wearable hybrid assistive limb for patients with bleeding disorders: study protocol for a randomised controlled trial. BMJ open 13 (11) (2023)
Hiroaki Yaoi, Yasuaki Shida, Kenichi Ogiwara, Takehisa Kitazawa, Midori Shima, Keiji Nogami
Emicizumab enhances thrombus formation in vitro under high shear flow conditions in whole blood from patients with type 1 and type 3 von Willebrand disease. Haemophilia : the official journal of the World Federation of Hemophilia 28 (5) (2022)
Midori Shima, Hideyuki Takedani, Kaoru Kitsukawa, Masashi Taki, Akira Ishiguro, Azusa Nagao, Haruko Yamaguchi-Suita, Yui Kyogoku, Seitaro Yoshida, Keiji Nogami
AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab - protocol for a multicentre, open-label, phase IV clinical study. BMJ open 12 (6) (2022)
Michael U Callaghan, Elina Asikanius, Michaela Lehle, Johannes Oldenburg, Johnny Mahlangu, Marianne Uguen, Sammy Chebon, Rebecca Kruse-Jarres, Víctor Jiménez-Yuste, Midori Shima, Peter Trask, Christine L Kempton, Craig M Kessler, Gallia G Levy, Flora Peyvandi
Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1-3. Research and practice in thrombosis and haemostasis 6 (6) (2022)
Kenichi Ogiwara, Masashi Taki, Takashi Suzuki, Hideyuki Takedani, Tadashi Matsushita, Kagehiro Amano, Masanori Matsumoto, Kenji Nishio, Midori Shima, Masato Kasahara, Keiji Nogami
Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial. BMJ open 12 (2) (2022)
Keiji Nogami, Masashi Taki, Tadashi Matsushita, Tetsuhito Kojima, Toshiaki Oka, Shouichi Ohga, Kiyoshi Kawakami, Michio Sakai, Takashi Suzuki, Satoshi Higasa, Yasuo Horikoshi, Keiko Shinozawa, Shogo Tamura, Koji Yada, Masue Imaizumi, Yoshitoshi Ohtsuka, Fuminori Iwasaki, Masao Kobayashi, Junki Takamatsu, Hideyuki Takedani, Hisaya Nakadate, Yoko Matsuo, Takeshi Matsumoto, Teruhisa Fujii, Katsuyuki Fukutake, Akira Shirahata, Akira Yoshioka, Midori Shima, null null
Clinical conditions and risk factors for inhibitor-development in patients with haemophilia: A decade-long prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2). Haemophilia : the official journal of the World Federation of Hemophilia 28 (5) (2022)
Hiroaki Yaoi, Yasuaki Shida, Takehisa Kitazawa, Midori Shima, Keiji Nogami
Emicizumab improves thrombus formation of type 2A von willebrand disease under high shear condition. Haemophilia : the official journal of the World Federation of Hemophilia 27 (2) (2021)
Mark W Skinner, Claude G Negrier, Ido Paz-Priel, Sammy Chebon, Victor Jimenez Yuste, Michael U Callaghan, Michaela Lehle, Markus Niggli, Johnny N Mahlangu, Amy D Shapiro, Midori Shima, Avrita Campinha-Bacote, Gallia G Levy, Johannes Oldenburg, Sylvia von Mackensen, Steven W Pipe
The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies. Haemophilia : the official journal of the World Federation of Hemophilia 27 (5) (2021)
Yasuko Furuichi, Keiji Nogami, Koji Yada, Satoko Nezu, Kenji Obayashi, Keigo Saeki, Norio Kurumatani, Mitsuru Nakajima, Seiji Kinoshita, Midori Shima
Assessment of self-/parent-reported quality of life in Japanese children with haemophilia using the Japanese version of KIDSCREEN-52. Haemophilia : the official journal of the World Federation of Hemophilia 26 (2) (2020)
Maria Elisa Mancuso, Johnny N Mahlangu, Robert Sidonio, Peter Trask, Marianne Uguen, Tiffany Chang, Midori Shima, Guy Aaron Young, Johannes Oldenburg, Sylvia von Mackensen
Health-related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors-Results from the HAVEN 2 study. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
Charles R M Hay, Midori Shima, Michael P Makris, Victor Jiménez-Yuste, Johannes Oldenburg, Kathelijn Fischer, Alfonso Iorio, Mark W Skinner, Elena Santagostino, Sylvia von Mackensen, Craig M Kessler
Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
Midori Shima, Azusa Nagao, Masashi Taki, Tadashi Matsushita, Koichi Oshida, Kagehiro Amano, Sayaka Nagami, Norihiro Okada, Shingo Maisawa, Keiji Nogami
Long-term safety and efficacy of emicizumab for up to 5.8 years and patients' perceptions of symptoms and daily life: A phase 1/2 study in patients with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 27 (1) (2020)
Naruto Shimonishi, Keiji Nogami, Kenichi Ogiwara, Tomoko Matsumoto, Fumie Nakazawa, Tetsuhiro Soeda, Michinori Hirata, Nobuo Arai, Midori Shima
Emicizumab improves the stability and structure of fibrin clot derived from factor VIII-deficient plasma, similar to the addition of factor VIII. Haemophilia : the official journal of the World Federation of Hemophilia 26 (3) (2020)
Midori Shima, Robert F Sidonio
Substitution therapy. Haemophilia : the official journal of the World Federation of Hemophilia (2020)
Yuka Kondo, Yasuaki Shida, Tomoaki Ishikawa, Koji Yada, Masahiro Takeyama, Midori Shima, Keiji Nogami
A case of moderate haemophilia A with inhibitor, carrying the p.R1800H mutation, complicated with juvenile idiopathic arthritis. Haemophilia : the official journal of the World Federation of Hemophilia 25 (1) (2018)